Metoprololtartraat Aurobindo

Metoprolol Tartrate, the active ingredient in Metoprololtartraat Aurobindo, is a beta blocker presented as a tablet for oral use. It is used to manage high blood pressure, angina, and certain cardiac rhythm disorders in adult patients. GNH USA supplies Metoprololtartraat Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprololtartraat Aurobindo is a selective β1‑blocker that acts on the cardiovascular system to control pressure and rhythm.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival by reducing cardiac workload after an acute event. - Heart failure: helps improve left‑ventricular function and symptoms. - Cardiac arrhythmias: controls heart rate in supraventricular tachycardia and atrial fibrillation.

Metoprololtartraat Aurobindo may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness - Dizziness, especially on standing - Cold extremities or reduced peripheral circulation - Gastrointestinal upset such as nausea or abdominal discomfort - Sleep disturbances including vivid dreams - Mild bradycardia (heart rate <60 bpm)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Acute heart failure exacerbation - Bronchospasm in patients with reactive airway disease - Hypotensive crisis with syncope - Depression or mood changes - Allergic reactions such as rash, angioedema, or anaphylaxis

Before initiating therapy, consider the following precautions.

- Cardiac function: assess for decompensated heart failure or severe bradycardia. - Respiratory status: avoid in uncontrolled asthma or chronic obstructive pulmonary disease. - Diabetes: monitor blood glucose as β‑blockade may mask hypoglycaemia symptoms. - Thyroid disease: use cautiously in hyper‑ or hypothyroidism. - Concomitant drugs: review for interactions that may exacerbate bradycardia or hypotension. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metoprololtartraat Aurobindo can interact with several medicines.

Major Interactions (Avoid): - Non‑selective β‑blockers: additive bradycardia and hypotension. - Calcium channel blockers (verapamil, diltiazem): profound AV‑node depression. - Antidiabetic agents: may mask hypoglycaemia signs. - Potassium‑sparing diuretics: risk of hyperkalaemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced blood pressure lowering. - NSAIDs: may reduce antihypertensive effect. - Antidepressants (SSRIs, SNRIs): possible increase in plasma metoprolol levels. - Antithyroid drugs: may alter heart rate response.